BB Biotech AG Financials

Market Capitalization CHF1.67 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	13.34
Forward PE	7.83
Price to Sales TTM	CHF-10.51
Price to Book MRQ	CHF0.86
Enterprise to Revenue	-9.95
Enterprise to EBITDA

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	0.00%
Operating Margin	-5619.44%
Return on Assets TTM	-4.91%
Return on Equity TTM	-19.26%

Income Statement

Revenue TTM	CHF-158,968,992
Revenue per Share TTM	CHF-2.90
Quarterly Revenue Growth	-100.00%
Gross Profit TTM	CHF-158,968,992
EBITDA	CHF0
Net Income to Common TTM	CHF-425,528,992
Diluted EPS TTM	CHF-7.77
Quarterly Earnings Growth YoY	-191.12%

Balance Sheet

Total Cash MRQ	CHF70,177,000
Total Cash per Share MRQ	CHF1.28
Total Debt MRQ	CHF
Total Debt to Equity MRQ	0.00
Current Ratio MRQ	441.22
Book Value per Share MRQ	CHF35.55

Cash Flow

Operating Cash Flow TTM	CHF522,468,000
Levered Free Cash Flow TTM	CHF-1,997,698,816

BION Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	54,762,000
Float Shares	None
Avg 10 Volume	60,138
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	0.08%
% Held by Institutions	11.66%

Stock Price Summary

Beta	0.81
Fifty Two Week Low	CHF24.35
Fifty Two Week High	CHF44.15
Fifty Two Week Change	-30.28%
Day 50 MA	CHF29.71
Day 200 MA	CHF34.20

Dividends and Splits

Forward Annual Dividend Rate	CHF7.20
Forward Annual Dividend Yield	23.68%
Trailing Annual Dividend Rate	CHF1.80
Trailing Annual Dividend Yield	5.92%
Payout Ratio	87.34%
Dividend Date	2025-03-25
Ex Dividend Date	2025-03-21
Last Split Factor
Last Split Date	2016-03-29